Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to determine whether the new, long-acting, form of
risperidone, Risperdal Consta, improves the ability of schizophrenia patients to benefit from
skills training. The hypothesis guiding this study is that Risperdal Consta, by improving
verbal memory, will improve the ability to benefit from skills training interventions among
schizophrenia patients. The primary objective of this study is to compare patients on
Risperdal Consta to patients on other atypical antipsychotic medications in terms of their
ability to benefit from skills training interventions. A secondary objective of this study is
to determine whether patients taking Risperdal Consta improve in other areas of cognitive
functioning and social functioning.
Phase:
Phase 3
Details
Lead Sponsor:
University of Illinois at Chicago
Collaborators:
Janssen, LP Weill Medical College of Cornell University